Steve Tuller

Steve Tuller is Vice President of Quality Assurance at Theseus Pharmaceuticals. Steve has 24 years of experience in the pharmaceutical and biotechnology industries. He most recently served as Vice President, Head of QA at Epizyme, Inc. where he initiated the GxP QA organization. In his role at Epizyme he led a successful FDA Pre-Approval Inspection for Tazverik and was responsible for clinical/commercial QA functions and Computer Systems Validation compliance. Prior to that from 2014-2016 Steve was Head of QA at Bind Therapeutics and held positions of increasing responsibility in QA, QC, and Analytical Development at Vertex, Advancis Pharma, and Shepherd Chemical. Steve has a B.S. in Chemistry from East Tennessee State University.